The FDA has granted rusfertide breakthrough therapy designation for patients with polycythemia vera, a step that could speed ...

Dr. Neal Patel says biopsy results may not fully capture prostate cancer risk, stressing that PSA, stage and disease volume ...

The FDA approved Monjuvi with Revlimid and Rituxan for follicular lymphoma, the same combination that brought survivor Troy ...

In patients with high-risk myelodysplastic syndromes, hypomethylating agents are underutilized, particularly among older, ...

A survivor shares how family, care teams and mentoring others helped her face stage 3C ovarian cancer and reclaim ...